Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Theodosakis

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|February 8, 2026
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Psoriasis and Comorbid Type 2 Diabetes: A Population-based Target Trial EmulationDebby Cheng, Helen Ji, Nicholas Theodosakis, et al.
Journal of the American Academy of Dermatology|May 10, 2024
A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States populationEthiopia D Getachew, Kanika Kamal, Katherine Young, et al.
Archives of Dermatological Research|May 17, 2024
Racial and ethnic differences in melasma treatment patterns: a multi-institution studyEthiopia D Getachew, Kanika Kamal, Katherine Young, et al.
Cell Reports|March 1, 2016
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTORGoran Micevic, Viswanathan Muthusamy, William Damsky, et al.
BMC Genomics|June 16, 2016
Genome-wide characterization of human L1 antisense promoter-driven transcriptsSteven W Criscione, Nicholas Theodosakis, Goran Micevic, et al.
Journal of Drugs in Dermatology : JDD|September 7, 2021
Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program LeadershipZizi Yu, Nicholas Theodosakis, Margaret W Cavanaugh-Hussey, et al.
The Journal of Investigative Dermatology|June 11, 2017
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein SynthesisNicholas Theodosakis, Goran Micevic, Casey G Langdon, et al.
Archives of Dermatological Research|January 22, 2024
Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case-control study in the All of Us Research ProgramKanika Kamal, David H Xiang, Katherine Young, et al.
Pigment Cell & Melanoma Research|October 4, 2018
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancerNicholas Theodosakis, Casey G Langdon, Goran Micevic, et al.
The Annals of Thoracic Surgery|May 1, 2012
Tumor recurrence after complete resection for non-small cell lung cancerMatthew D Taylor, Alykhan S Nagji, Castigliano M Bhamidipati, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|February 8, 2026
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Psoriasis and Comorbid Type 2 Diabetes: A Population-based Target Trial EmulationDebby Cheng, Helen Ji, Nicholas Theodosakis, et al.
Journal of the American Academy of Dermatology|May 10, 2024
A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States populationEthiopia D Getachew, Kanika Kamal, Katherine Young, et al.
Archives of Dermatological Research|May 17, 2024
Racial and ethnic differences in melasma treatment patterns: a multi-institution studyEthiopia D Getachew, Kanika Kamal, Katherine Young, et al.
Cell Reports|March 1, 2016
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTORGoran Micevic, Viswanathan Muthusamy, William Damsky, et al.
BMC Genomics|June 16, 2016
Genome-wide characterization of human L1 antisense promoter-driven transcriptsSteven W Criscione, Nicholas Theodosakis, Goran Micevic, et al.
Journal of Drugs in Dermatology : JDD|September 7, 2021
Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program LeadershipZizi Yu, Nicholas Theodosakis, Margaret W Cavanaugh-Hussey, et al.
The Journal of Investigative Dermatology|June 11, 2017
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein SynthesisNicholas Theodosakis, Goran Micevic, Casey G Langdon, et al.
Archives of Dermatological Research|January 22, 2024
Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case-control study in the All of Us Research ProgramKanika Kamal, David H Xiang, Katherine Young, et al.
Pigment Cell & Melanoma Research|October 4, 2018
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancerNicholas Theodosakis, Casey G Langdon, Goran Micevic, et al.
The Annals of Thoracic Surgery|May 1, 2012
Tumor recurrence after complete resection for non-small cell lung cancerMatthew D Taylor, Alykhan S Nagji, Castigliano M Bhamidipati, et al.
Pageof 6